Sana Biotechnology (SANA) Other Working Capital Changes (2020 - 2026)

Sana Biotechnology has reported Other Working Capital Changes for 7 years, with the latest figure at -$1.6 million in Q1 2026.

• Quarterly Other Working Capital Changes fell 19.01% year-over-year to -$1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 506.38% YoY) and the FY2025 annual result came in at -$1.2 million, down 133.16% from the prior year.
• Other Working Capital Changes eased to -$1.6 million in Q1 2026 per SANA's latest filing, from $696000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $6.6 million in Q4 2022 and troughed at -$5.5 million in Q2 2023.
• A 5-year average of -$84411.8 and a median of -$678000.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes slumped 2513.33% in 2022, then jumped 2145.28% in 2024.
• Over 5 years, Other Working Capital Changes stood at $6.6 million in 2022, then tumbled by 139.39% to -$2.6 million in 2023, then fell by 26.52% to -$3.3 million in 2024, then jumped by 121.3% to $696000.0 in 2025, then slumped by 333.91% to -$1.6 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$1.6 million, $696000.0, and -$1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.